319 related articles for article (PubMed ID: 18420396)
1. Thermodynamic behavior of glassy state of structurally related compounds.
Kaushal AM; Bansal AK
Eur J Pharm Biopharm; 2008 Aug; 69(3):1067-76. PubMed ID: 18420396
[TBL] [Abstract][Full Text] [Related]
2. Correlating thermodynamic and kinetic parameters with amorphous stability.
Graeser KA; Patterson JE; Zeitler JA; Gordon KC; Rades T
Eur J Pharm Sci; 2009 Jun; 37(3-4):492-8. PubMed ID: 19394421
[TBL] [Abstract][Full Text] [Related]
3. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
Gupta P; Chawla G; Bansal AK
Mol Pharm; 2004; 1(6):406-13. PubMed ID: 16028352
[TBL] [Abstract][Full Text] [Related]
4. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
5. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.
Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
J Pharm Sci; 2002 Aug; 91(8):1863-72. PubMed ID: 12115813
[TBL] [Abstract][Full Text] [Related]
6. Correlation between glass-forming ability and fragility of pharmaceutical compounds.
Kawakami K; Harada T; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H
J Phys Chem B; 2015 Apr; 119(14):4873-80. PubMed ID: 25781503
[TBL] [Abstract][Full Text] [Related]
7. Calorimetric relaxation in pharmaceutical molecular glasses and its utility in understanding their stability against crystallization.
Tombari E; Ferrari C; Johari GP; Shanker RM
J Phys Chem B; 2008 Sep; 112(35):10806-14. PubMed ID: 18683970
[TBL] [Abstract][Full Text] [Related]
8. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation.
Bansal SS; Kaushal AM; Bansal AK
Pharmazie; 2008 Nov; 63(11):812-4. PubMed ID: 19069241
[TBL] [Abstract][Full Text] [Related]
9. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
10. Early drug development predictions of glass-forming ability and physical stability of drugs.
Mahlin D; Bergström CA
Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
[TBL] [Abstract][Full Text] [Related]
11. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
12. Effect of counterions on the properties of amorphous atorvastatin salts.
Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
[TBL] [Abstract][Full Text] [Related]
13. Rheology and molecular mobility of amorphous blends of citric acid and paracetamol.
Hoppu P; Hietala S; Schantz S; Juppo AM
Eur J Pharm Biopharm; 2009 Jan; 71(1):55-63. PubMed ID: 18656536
[TBL] [Abstract][Full Text] [Related]
14. Influence of substrate temperature on the stability of glasses prepared by vapor deposition.
Kearns KL; Swallen SF; Ediger MD; Wu T; Yu L
J Chem Phys; 2007 Oct; 127(15):154702. PubMed ID: 17949186
[TBL] [Abstract][Full Text] [Related]
15. Determination of Fragility in Organic Small Molecular Glass Forming Liquids: Comparison of Calorimetric and Spectroscopic Data and Commentary on Pharmaceutical Importance.
Chakravarty P; Pandya K; Nagapudi K
Mol Pharm; 2018 Mar; 15(3):1248-1257. PubMed ID: 29384682
[TBL] [Abstract][Full Text] [Related]
16. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
Li H; Kiang YH; Jona J
Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
[TBL] [Abstract][Full Text] [Related]
17. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
[TBL] [Abstract][Full Text] [Related]
18. Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development.
Mahlin D; Ponnambalam S; Höckerfelt MH; Bergström CA
Mol Pharm; 2011 Apr; 8(2):498-506. PubMed ID: 21344945
[TBL] [Abstract][Full Text] [Related]
19. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.
Haddadin R; Qian F; Desikan S; Hussain M; Smith RL
Pharm Dev Technol; 2009; 14(1):18-26. PubMed ID: 18825543
[TBL] [Abstract][Full Text] [Related]
20. Vitrification of two active pharmaceutical ingredients by fast scanning calorimetry: From structural relaxation to nucleation phenomena.
Monnier X; Viel Q; Schammé B; Petit S; Delbreilh L; Dupray V; Coquerel G; Dargent E
Int J Pharm; 2018 Jan; 536(1):426-433. PubMed ID: 29225097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
